Loading Events

Arizona Fall Chapter Program

October 22, 2022

8:00 am MST -12:30 pm MST

Join us for a complimentary educational event this fall, where you can network with colleagues, earn 3.0 CE (including 0.5 Pharm) contact hours and learn more about PCNA. Hosted by the Arizona Chapter.

PCNA members and non-members are welcome to register and attend. Please share this with colleagues and friends.

Agenda

8:00     Welcome & Breakfast
8:20     Presentation by Janssen (non-CE)
9:20     Preventing and Managing VTE: Matching Patient Need to Optimal Therapy (1 CE, 0.5 Pharm)
10:20   12 Lead ECG Interpretation (1 CE)
11:20    ASCVD Risk Estimation and Communication (1 CE)
12:20   Closing

Presentation Topics

Preventing and Managing VTE: Matching Patient Need to Optimal Therapy (1.0 CE, 0.5 Pharm)

Learning Objectives

  • Identify prevalence rates of venous thromboembolism (VTE), including rates for morbidity and mortality
  • Define professional guidelines for assessing risk in patients with VTE and discuss recommendations for patient management
  • Describe methods and tools for ensuring effective communication with patients and caregivers as a means of improving adherence and self-care in patients with VTE

12 Lead ECG Interpretation (1.0 CE contact hours)

Learning Objectives

  • Review components of the 12-lead ECG.
  • Explain 12-lead ECG interpretation techniques.
  • Discuss patient care considerations of specific ECG findings including prolonged QT, HCM, WPW, and more.
  • Apply 12-lead ECG interpretation techniques through hands-on practice.

ASCVD Risk Estimation and Communication (1.0 CE contact hours)

Learning Objectives

  • Describe modifiable and non-modifiable risk factors and enhancers that are known to increase the risk of atherosclerotic cardiovascular disease (ASCVD).
  • Explain currently available ASCVD risk estimation tools.
  • Apply tools that can predict risk for ASCVD across patient populations using a case study approach.
  • Summarize Coronary Artery Calcium Scoring considerations.